The story of Viagra and the pharmaceutical industry presents a complex picture for careful investors. Initially, copyright's blockbuster drug transformed the treatment of erectile dysfunction, creating significant profits and defining the contemporary pharmaceutical landscape. However, patent expiration and the appearance of off-brand versions have